A method for preparing On-DNA sulfonamide compounds by electrochemical reaction

Synthesis of ON-DNA sulfonamide compounds on DNA through electrochemical reactions has solved the problems of limitation of diversity and DNA damage in the prior art, and achieved a library of ON-DNA sulfonamide compounds with high yield and DNA integrity. Construction provides new application prospects for drug development.

CN118461019BActive Publication Date: 2024-12-03PHARMARON NINGBO CO LTD +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410663875.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-05-27
Publication Date
2024-12-03
Estimated Expiration
2044-05-27

AI Technical Summary

Technical Problem

In the prior art, the diversity of ON-DNA sulfonamide compounds in DNA encoding libraries is limited, especially in the synthesis of fatty sulfonyl chloride sulfonamides. The electrochemical reaction is not suitable for DNA, and the equipment requirements are complex, resulting in Loss of molecular diversity and risk of DNA damage.

Method used

The ON-DNA sulfonamide compound was synthesized by electrochemical reaction, and the oligonucleic acid-terminal amine compound was electrochemically reacted with sodium sulfinate and electrolyte under the platinum wire electrode to form an oligonucleic acid-sulfonamide structural compound. The conditions include a final concentration of 0.01 to 1.0 mmol/liter, 50 to 1000 equivalents of sodium sulfinate, 25 to 300 equivalents of electrolyte and solvent, and a voltage of 0.5 to 3.0 V is applied, and the reaction is carried out for more than 15 minutes.

Benefits of technology

The construction of the ON-DNA sulfonamide compound library with high yield and DNA integrity has enriched the chemical reaction types of the DNA encoding compound library, overcome the problems of diversity loss and DNA damage in the prior art, and provided new Drug development prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDA0005096688180000011
    Figure FDA0005096688180000011
  • Figure FDA0005096688180000012
    Figure FDA0005096688180000012
  • Figure GDA0005085473920000011
    Figure GDA0005085473920000011
Patent Text Reader

Abstract

This application belongs to the field of construction of lead compound libraries in medical research, and specifically relates to a method for constructing an On-DNA sulfonamide compound library. This application uses electrochemical reactions to synthesize On-DNA sulfonamide compounds, specifically mixing an oligonucleic acid-terminal amine compound at a final concentration of 0.01 to 1.0 mmol / L, 50 to 1000 equivalents of a sodium sulfinate reagent, 25 to 300 equivalents of an electrolyte and a solvent, using platinum wire as positive and negative electrodes at 0 to 35°C, applying a voltage of 0.5V to 3.0V, and reacting for more than 15 minutes to convert into an oligonucleic acid-sulfonamide structure compound, with mild reaction conditions and a conversion rate of up to 99%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application belongs to the field of construction of lead compound libraries in medical research, and specifically relates to a method for constructing an On-DNA sulfonamide compound library. Background Art

[0002] Sulfonamides are a very important class of compounds in medicine and synthetic chemistry. In fact, the sulfonamide functional group is a structural group of many drugs and bioactive compounds, with antibacterial, antitumor, anti-inflammatory, hypoglycemic and protease inhibitory activities. Therefore, the search for new and efficient preparation methods for sulfonamide drugs remains a hot topic. Among them, Baricitinib Tablets (Baricitinib) was officially approved by the China National Medical Products Administration (NMPA) on March 27, 2023 for the systemic treatment of severe alopecia areata in adults. In July 2019, Baricitinib was approved in China for adult patients with moderate to severe active rheumatoid arthritis and entered the 2020 version of the National Medical Insurance Catalogue. Macitentan / Tadalafil is an orally active non-peptide dual ETA / ETB (endothelin) receptor dual antagonist used to treat idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). Sildenafil (Sildenafil) is a drug for the treatment of male erectile dysfunction that was accidentally invented during the development of drugs for the treatment of cardiovascular diseases. Sulfasalazine is a sulfonamide drug. After administration, it is decomposed into sulfonamide pyridine and 5-aminosalicylic acid by microorganisms in the distal small intestine and colon, and becomes effective. It is clinically used to treat acute and chronic ulcerative colitis.

[0003] DNA-encoded libraries (DELs) have become an important component of new drug identification. The power of DNA-encoded libraries (DELs) lies in the ability to screen billions of small molecules simultaneously in a test tube to determine their affinity to molecular targets of interest. Currently, high-throughput screening requires expensive specialized equipment, and this technology provides an alternative approach to high-throughput screening, potentially making the drug discovery process more accessible. Although DELs have proven to be valuable, the insolubility of DNA tags in organic solvents and their rich functional group specificity limit the synthetic methods that can be used to design small molecule library members, and also limit the molecular diversity of the resulting libraries. Therefore, it is of great significance to develop chemical synthesis methods that are compatible with DEL synthesis and can be used to increase molecular diversity.

[0004] In the prior art, a method for preparing ON-DNA-sulfonamide by nucleophilic reaction of amine and sulfonyl chloride is disclosed. The specific reaction equation of the method is as follows: In this method, sulfonyl chloride (b) is used as an electrophilic reagent. Therefore, the more electron-deficient the sulfonyl chloride is, the more favorable it is to the reaction. Therefore, this method selects sulfonyl chloride with an aromatic ring as an electrophilic reagent to prepare the product (C) in which R3 is an aromatic structure. When R3 is required to be a fatty substituent, then R3 in the electrophilic reagent (b) is required to be an aliphatic substituent. If the electrophilic reagent (b) is a fatty substituent, then due to the electron-donating effect of the fatty substituent, the electron cloud density of the sulfonyl group will increase, and the electron-donating effect will gradually increase with the increase of the length of the fatty chain, which will make the nucleophilic substitution reaction difficult to proceed, and ultimately lead to the lack of diversity of ON-DNA-sulfonamide compounds.

[0005] In the prior art, those skilled in the art generally believe that electrochemical reactions may damage DNA and require complex equipment, and therefore are not suitable for large-scale construction of DEL libraries. In addition, the existing ON-DNA-sulfonamide method cannot be used for the synthesis of fatty sulfonyl chloride sulfonamides. The present invention can successfully complete such reactions. Summary of the invention

[0006] In order to solve the above technical problems, the present application provides an on-DNA chemical reaction with a wide substrate adaptability compared to the above prior art, that is, an on-DNA sulfonamide compound is synthesized by electrochemical reaction, specifically, 0.01 to 1.0 mmol / L final concentration of oligonucleic acid-terminal amine compound (Formula I), 50 to 1000 equivalents of sodium sulfinate reagent (Formula II), 25 to 300 equivalents of electrolyte and solvent are mixed, platinum wire is used as positive and negative electrodes at 0 to 35°C, 0.5V to 3.0V voltage is applied, and the reaction is carried out for more than 15 minutes to convert into an oligonucleic acid-sulfonamide structure compound (Formula III). The specific reaction equation is as follows: The oligonucleic acid in the structural formula is a single-stranded or double-stranded nucleotide chain obtained by polymerization of artificially modified or unmodified nucleotide monomers.

[0007] -XY-Selected R 1 Selected from the following groups: 5-6 membered aryl, 5-6 membered heteroaryl, 3-5 membered saturated cycloalkyl, 3-6 membered saturated heterocyclic group, C2-12 alkyl;

[0008] R 2 Selected from the following groups: C2-8 alkyl, hydrogen atom.

[0009] R 3 Selected from the following substituted or unsubstituted groups: 5-6 membered aryl, 5-6 membered heteroaryl, 3-6 membered saturated cycloalkyl, 3-6 membered saturated heterocyclic group, C2-12 alkyl; wherein the substituent is halogen or alkyl.

[0010] In some embodiments, the final concentration of the oligonucleic acid-terminal amine compound is 0.01 to 1.0 mmol / L; in some preferred embodiments, the final concentration of the oligonucleic acid-terminal amine compound is 0.05 to 0.5 mmol / L; in some more preferred embodiments, the concentration of the oligonucleic acid-terminal amine compound is a final concentration of 0.05 to 0.3 mmol / L, and more preferably the concentration of the oligonucleic acid-terminal amine compound is a final concentration of 0.1 to 0.3 mmol / L.

[0011] In some embodiments, with 1 equivalent of the oligonucleic acid-terminal amine compound as a reference, the sodium sulfite equivalent is 50 to 1000 equivalents; in some preferred embodiments, the sodium sulfite equivalent is 100 to 800; in some more preferred embodiments, the sodium sulfite equivalent is 200 to 800 equivalents, and optionally can be 100 to 250 equivalents.

[0012] In some embodiments, with 1 equivalent of the oligonucleic acid-terminal amine compound as a reference, the electrolyte equivalent is 20 to 300 equivalents; in some preferred embodiments, the electrolyte equivalent is 50 to 250; in some more preferred embodiments, the electrolyte equivalent is 100 to 200 equivalents.

[0013] In some embodiments, the electrolyte of the reaction is any one of sodium iodide (NaI), N-chlorosuccinimide (NCS), tetrabutylammonium iodide (TBAI), sodium bromide (NaBr), potassium bromide (KaBr), iodinated ammonium (NH4I), sodium chloride (NaCl), and potassium iodide (KI). In some preferred embodiments, the electrolyte of the reaction is any one of sodium iodide (NaI) and tetrabutylammonium iodide (TBAI); in some more preferred embodiments, the electrolyte of the reaction is sodium iodide (NaI).

[0014] In some embodiments, the solvent of the reaction is any one or a mixture of water, methanol (MeOH), ethanol (EtOH), acetonitrile (MeCN), tetrahydrofuran (THF), 1,4-dioxane (1,4-Dioxane), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), dichloromethane (DCM), dimethyl sulfoxide (DMSO). In some preferred embodiments, the solvent of the reaction is any one or a mixture of water, ethanol (EtOH), N,N-dimethylacetamide (DMA), dichloromethane (DCM), dimethyl sulfoxide (DMSO); in some more preferred embodiments, the solvent of the reaction is water.

[0015] In some embodiments, the reaction temperature is 0°C to 35°C, such as 0°C, 10°C, 15°C, 20°C, 30°C, and 35°C; in some preferred embodiments, the reaction temperature is 15 to 30°C, such as 15°C, 20°C, and 30°C; in some more preferred embodiments, the reaction temperature is 20 to 27°C, such as 20°C, 23°C, and 27°C.

[0016] In some embodiments, the total reaction time is more than 15 minutes; in some preferred embodiments, the total reaction time is more than 30 minutes; in some more preferred embodiments, the total reaction time is more than 60 minutes.

[0017] Those skilled in the art generally believe that electrochemical reaction conditions are cumbersome, for example, each individual reaction channel must be energized, and the amount of reaction on DNA is generally small. However, the large-scale construction of an oligonucleic acid-sulfonamide compound library is achieved in this application.

[0018] In addition, it is well known in the art that DNA must remain stable under certain conditions; the reaction used in the construction of DNA-encoded compound libraries needs to have a high yield. Under the reaction conditions of the present invention, the oligonucleotide-sulfonamide structure compound not only has a high yield, but also has good DNA integrity. The integrity of the compound can be confirmed not only from liquid chromatography mass spectrometry, but also by performing the next step of DNA enzyme catalytic coupling reaction (please refer to "Spectrum data of the product after oligonucleotide-sulfonamide structure compound is connected to oligo A, Fig.15 The present invention enriches the chemical reaction types for synthesizing a coding compound library on DNA, constructs a new oligonucleic acid-sulfonamide structure compound for synthesizing a DNA coding compound library, and has a very good application prospect in the development of lead drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 :Structure of raw material HP(S1)

[0020] Figure 2 :Liquid chromatography mass spectrometry detection spectrum of DNA-NHFmoc(S2)

[0021] Figure 3 :Liquid chromatography mass spectrometry detection spectrum of DNA-NH2(S3)

[0022] Figure 4 :DNA-COOH(S4) liquid chromatography mass spectrometry detection spectrum

[0023] Figure 5 :Liquid chromatography mass spectrometry detection spectrum of raw material polynucleic acid-terminal amine 1a-1c structure compound

[0024] Figure 6 :Liquid chromatography mass spectrometry detection spectrum of raw material polynucleic acid-terminal amine 1d-1f structure compound

[0025] Figure 7 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P1-P3 structure compound

[0026] Figure 8 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P4-P6 structure compound

[0027] Fig. 9 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P7-P9 structure compound

[0028] Fig.10 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P10-P12 structure compound

[0029] Fig.11 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P13-P15 structure compound

[0030] Fig.12 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P16-P18 structure compound

[0031] Fig.13 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P19-P21 structural compound

[0032] Fig.14 :Liquid chromatography mass spectrometry detection spectrum of oligonucleic acid-sulfonamide P22-P24 structure compound

[0033] Fig.15 : Experimental spectrum of DNA integrity verification in oligonucleic acid-sulfonamide structure compounds DETAILED DESCRIPTION

[0034] 1. Synthesis of oligonucleic acid-NH2 raw material (S3)

[0035] 1.1 Synthesize oligonucleic acid-NHFmoc raw material (S2) according to the following reaction formula:

[0036]

[0037] 100 nanomoles of HP (S1, HP has the structure Figure 1As shown, it is a commercial product) dissolved in deionized water to prepare a 1 mmol / L solution (100 μL, 1 equivalent). 40 equivalents of the starting head fragment compound (commercial product) in DMSO solution (20 μL, 200 mmol / L), 250 equivalents of sodium tetraborate (Na2B4O7) buffer solution with pH = 9.5 (100 μL, 250 mmol / L), and 40 equivalents of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (DMT-MM) aqueous solution (20 μL, 200 mmol / L) were mixed, and the mixture was fully mixed with a vortex oscillator. Then, the above mixture was added to the HP solution, mixed evenly, and reacted at 4°C for 1 hour. After the reaction was completed, 10% of the total volume of 5 mol / L sodium chloride solution was added to the reaction solution. Then, 3 times the total volume of anhydrous ethanol was added, and after oscillation, the reaction solution was placed in a refrigerator at -80°C for 2 hours. Afterwards, the mixture was centrifuged at 4000 rpm for half an hour, and the supernatant was discarded. The remaining precipitate was dissolved in deionized water to obtain a DNA-NHFmoc solution. The spectrum of DNA-NHFmoc (S2) was detected by liquid chromatography-mass spectrometry. Figure 2 As shown, its molecular weight is 5406.

[0038] 1.2 Synthesize oligonucleic acid-NH2 raw material (S3) according to the following reaction formula:

[0039]

[0040] Dissolve 100 nanomoles of DNA-NHFmoc (S2) in deionized water to make 1 mmol / L (100 microliters, 1 equivalent), add 56 microliters of 10% piperidine aqueous solution, mix the two evenly and react at room temperature for 1 hour. After the reaction is completed, add 10% of the total volume of 5 mol / L sodium chloride solution to the reaction solution. Then, continue to add 3 times the total volume of anhydrous ethanol, shake evenly, and freeze the reaction in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000rpm for half an hour and pour off the supernatant. The remaining precipitate is dissolved in deionized water to obtain a solution of oligonucleic acid-NH2 (S3, abbreviated as DNA-NH2). The spectrum of DNA-NH2 (S3) detected by liquid chromatography-mass spectrometry is as shown Figure 3 As shown, its molecular weight is 5184.

[0041] 2. Synthesis of oligonucleic acid-COOH raw material (S4)

[0042] 2.1 Synthesize oligonucleic acid-COOH raw material (S4) according to the following reaction formula:

[0043]

[0044] 100 nanomoles of HP (S1, HP has the structure Figure 1 40 equivalents of the starting head fragment compound 3,6,9,12-tetraoxacyclohexane diacid (commercial product) in DMSO solution (concentration: 200 mmol / L), 250 equivalents of sodium tetraborate (Na2B4O7) buffer solution at pH = 9.5 (concentration: 250 mmol / L), and 40 equivalents of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (DMT-MM) aqueous solution (concentration: 200 mmol / L) were mixed, and the mixture was thoroughly mixed with a vortex oscillator. The above mixture was then added to the HP solution, mixed evenly, and reacted at 4°C for 1 hour. After the reaction was completed, 10% of the total volume of 5 mol / L sodium chloride solution was added to the reaction solution. Then, continue to add anhydrous ethanol 3 times the total volume, shake evenly, and place the reaction solution in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000rpm for half an hour, and pour out the supernatant. The remaining precipitate is dissolved in deionized water to obtain a DNA-COOH solution. The spectrum of DNA-COOH (S4) detected by liquid chromatography-mass spectrometry is as follows Figure 4 As shown, its molecular weight is 5229.

[0045] 3. Synthesis of raw material oligonucleic acid-terminal amine compound

[0046] 3.1 Synthesis of oligonucleic acid-terminal amine compounds from oligonucleic acid-COOH(S4)

[0047]

[0048] 100 nanomoles of DNA-COOH (S4) were dissolved in deionized water to prepare a solution with a concentration of 1 mmol / L (100 μL, 1 equivalent), and 50 equivalents of piperazine (commercially available, 25 μL, 200 mmol / L dimethyl sulfoxide solution), 50 equivalents of N,N-diisopropylethylamine (25 μL, 200 mol / L dimethyl sulfoxide solution), and 50 equivalents of O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU, 200 μL, 200 mmol / L dimethyl sulfoxide solution) were added thereto. After mixing well, the mixture was reacted at room temperature for 2 hours (references for the condensation reaction: Li Y.; Gabriele E.; Samain F.; Favalli N.; Sladojevich F.; Scheuermann.; Optimized Reaction Conditions for Amide Bond Formation in DNA Encoded Combinatorial Libraries, Neri D.ACS Comb.Sci.2016,18,8,438–443.). After the reaction is completed, 10% of the total volume of 5 mol / L sodium chloride solution is added to the reaction solution, and then 3 times the total volume of anhydrous ethanol is added. After oscillation, the reaction is placed in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000 rpm for half an hour at 4°C, pour off the supernatant, and dissolve the remaining precipitate in deionized water to obtain an oligonucleic acid-terminal amine compound aqueous solution. The spectrum of the oligonucleic acid-terminal amine compound 1a detected by liquid chromatography-mass spectrometry is as follows Figure 5 As shown, its molecular weight is 5296 and the conversion rate is >99%.

[0049] 3.2 Synthesis of oligonucleic acid-terminal amine compounds from oligonucleic acid-NH2(S3)

[0050]

[0051] 100 nanomoles of DNA-NH2(S3) were dissolved in deionized water to prepare a solution with a concentration of 1 mmol / L (100 μL, 1 equivalent), and 250 equivalents of sodium tetraborate (Na2B4O7) buffer (100 μL, 250 mmol / L) with a pH of 9.5, 100 equivalents of N-fluorenylmethoxycarbonyl-beta-alanine (commercially available, 50 μL, 200 mmol / L dimethyl sulfoxide solution), and 80 equivalents of 4-(4,6-dimethoxytriazine-2-yl)-4-methylmorpholine hydrochloride (DMT-MM) aqueous solution (40 μL, 200 mmol / L) were added thereto and mixed. The mixture was thoroughly mixed on a vortex oscillator and reacted at room temperature for 2 hours (references for the condensation reaction: Li Y.; Gabriele E.; Samain F.; Favalli N.; Sladojevich F.; Scheuermann.; Optimized Reaction Conditions for Amide Bond Formation in DNA Encoded Combinatorial Libraries, Neri D.ACS Comb.Sci.2016,18,8,438–443.). After the reaction is completed, add 10% of the total volume of 5 mol / L sodium chloride solution to the reaction solution, then add 3 times the total volume of anhydrous ethanol, shake evenly, and place the reaction in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000rpm for half an hour at 4°C, pour out the supernatant, dissolve the remaining precipitate with deionized water, add 40 microliters of 10% piperidine aqueous solution, mix the two evenly, and react at room temperature for 1 hour. After the reaction is completed, add 10% of the total volume of 5 mol / L sodium chloride solution to the reaction solution. Then, continue to add 3 times the total volume of anhydrous ethanol, shake evenly, and place the reaction in a -80°C refrigerator for 2 hours. After that, centrifuge at 4000rpm for half an hour, and pour out the supernatant. The remaining precipitate was dissolved in deionized water to obtain an aqueous solution of the oligonucleic acid-terminal amine compound. The spectrum of the oligonucleic acid-terminal amine compound 1b was detected by liquid chromatography-mass spectrometry. Figure 5 As shown, its molecular weight is 5256 and the conversion rate is >99%. The synthesis method of 1c-1f is the same as 1b. The corresponding structure, molecular weight and conversion rate are shown in Table 1. The spectrum is shown in Figure 5-6 shown.

[0052] Table 1

[0053]

[0054] 4. Taking the synthesis of polynucleic acid-sulfonamide compound P1 from oligonucleic acid-terminal amine 1a as an example, the reaction conditions for the synthesis of polynucleic acid-sulfonamide compound were optimized

[0055]

[0056] Table 2

[0057]

[0058]

[0059] Note: The final concentration of DNA is the final concentration of oligonucleotide-terminal amine compound

[0060] According to the experimental results, it can be seen that under the reaction conditions of No. 10, the yield of the obtained product P1 is as high as >99%.

[0061] Effect of reaction time: By comparing reactions 1-3, we can see that when the sodium benzenesulfinate equivalent is 200 equivalents, the sodium iodide equivalent is 50 equivalents, and the final DNA concentration is 0.05 mmol / L, as the time increases from 5 minutes to 30 minutes, the conversion rate of P1 does not change significantly; comparing reaction 3 with reaction 4, the sodium iodide equivalent is increased from 50 equivalents to 100 equivalents, the reaction time is still 30 minutes, and the conversion rate of P1 increases from 5% to 41%; comparing reaction 4 with reaction 7, simply extending the reaction time by 30 minutes, the conversion rate of P1 increases from 41% to 45%, so a reaction time of 30 minutes is a relatively sufficient condition, preferably more than 60 minutes.

[0062] Effect of sodium iodide dosage: By comparing reactions 3-6, we can see that when the sodium benzenesulfinate equivalent is 200 equivalents and the final DNA concentration is 0.05 mmol / L, at the same reaction time of 30 minutes, the sodium iodide dosage is in the range of 50-100 equivalents. As the amount of sodium iodide increases, the conversion rate gradually increases. When the sodium iodide dosage is 100 equivalents, the conversion rate is as high as 41%, but when the sodium iodide dosage is 150 equivalents, the conversion rate drops to about 20% again. By comparing reactions 10, 15-16, we can see that with the same final DNA concentration and reaction time, as the sodium iodide dosage increases, the conversion rate of P1 increases, but when the sodium iodide equivalent is 150 equivalents, the conversion rate is lower than that of 100 equivalents.

[0063] Comprehensive sodium iodide dosage and time: Comparison of reactions 5-6, when the sodium benzenesulfinate equivalent is 200 equivalents and the final DNA concentration is 0.05 mmol / L, the reaction time is 30 minutes, the sodium iodide dosage increases from 150 equivalents to 200 equivalents, and the conversion rate rises back to about 30%. When other conditions are the same as reaction 6, only the electrolyte sodium iodide equivalent is different from the reaction, that is, when the electrolyte dosage is 300eq, P1 (%) is 42.9%, which is not much different from 100eq; at the same time, the reaction time is increased to 60 minutes (compared with reaction 7), and the conversion rate of P1 is increased from 30% to 45%. Therefore, we believe that the dosage of sodium iodide is preferably 100 to 300 equivalents, and the reaction time is preferably more than 60 minutes. Of course, in order to fully react and not waste, the electrolyte equivalent can also be selected to be 100 to 200 equivalents.

[0064] Effect of final DNA concentration: By comparing reactions 7-12, we can see that when the sodium benzenesulfinate equivalent is 200 equivalents and the sodium iodide equivalent is 100 equivalents, and the reaction time is 60 minutes, the final DNA concentration is within the range of 0.05 mmol / L, and the conversion rate of P1 increases with the increase of the final DNA concentration. When the final DNA concentration is 0.2 mmol / L, the conversion rate of P1 can be increased to >99%; when the final DNA concentration continues to increase from 0.2 to 1.0, the conversion rate of P1 turns around and drops to 89%. Therefore, we believe that the preferred final DNA concentration is within the range of 0.05-1.0 mmol / L; the preferred final concentration of the oligonucleotide-terminal amine compound is 0.05-0.5 mmol / L, and more preferably the final concentration of the oligonucleotide-terminal amine compound is 0.05-0.5 mmol / L, or even 0.1-0.3 mmol / L.

[0065] By comparing reactions 10, 13-14, and 17-18, we can see that at the same final DNA concentration and reaction time, as the amount of sodium benzenesulfinate increases, the conversion rate of P1 will increase accordingly. However, when the sodium benzenesulfinate equivalent is 250 equivalents, the conversion rate is significantly lower than that at 200 equivalents. Therefore, we believe that the preferred range of sodium benzenesulfinate equivalents is 100 to 250 equivalents.

[0066] By comparing reactions 10, 19-25, we can see that the effect of solvent on the conversion rate of P1 is that the effects of DCM and H2O are significantly better than DMA, DMSO, EtOH, THF, and 1,4-Dioxane.

[0067] By comparing reactions 10, 26-31, we can see that the effect of electrolyte on the conversion rate of P1 is that the effects of NaI and TBAI are significantly better than those of NCS, NaBr, NH4I, NaCl, and KI; and the dosage of electrolyte is preferably 25-300 equivalents; more preferably 100-200 equivalents.

[0068] Effect of voltage: By comparing reactions 10, 32-34, we can see that at the same final DNA concentration and reaction time, the conversion rate of P1 increases with the increase of voltage, but when the voltage continues to rise from 2V to 3V, the conversion rate of P1 is significantly lower than that of 2V. Therefore, we believe that the optimal voltage is in the range of 0.5-3V.

[0069] Example 1: Synthesis of polynucleic acid-sulfonamide compound (P1) using raw material oligonucleic acid-terminal amine compound (1a)

[0070]

[0071] 200 equivalents of sodium benzenesulfinate solution (5 μl, 200 mmol / l aqueous solution), 100 equivalents of sodium iodide solution (commercially available, 5 μl, 100 mmol / l dimethyl sulfoxide solution) and 10 μl of water were added to an aqueous solution of 5 nanomoles of oligonucleic acid-terminal amine compound (1a, 1 mmol / l, 1 equivalent, 5 μl). The mixture was thoroughly mixed by vortexing, and a 2V voltage was applied using platinum wire (commercially available) as positive and negative electrodes, and the reaction was carried out at 25°C for 60 minutes. After the reaction, 10% of the total volume of 5 mol / L sodium chloride solution and 3 times of anhydrous ethanol were added to the reaction solution, and after being shaken evenly, it was placed in a refrigerator at -80°C for 2 hours, and then high-speed refrigerated centrifugation (4°C, 12000 rpm, 15 minutes), the supernatant was poured out, and the remaining precipitate was the product oligonucleic acid-sulfonamide compound (P1), which was detected by liquid chromatography-mass spectrometry. The detection results are shown in Figure 7 , molecular weight of 5437, conversion rate>99%.

[0072] Example 2: Synthesis of polynucleic acid-sulfonamide compound (P14) using raw material oligonucleic acid-terminal amine compound (1a)

[0073]

[0074] 800 equivalents of sodium ethylsulfinate solution (5 μl, 200 mmol / l aqueous solution), 200 equivalents of sodium iodide solution (commercially available, 5 μl, 100 mmol / l dimethyl sulfoxide solution) and 10 μl of water were added to an aqueous solution of 5 nanomoles of oligonucleic acid-terminal amine compound (1a, 1 mmol / l, 1 equivalent, 5 μl). The mixture was thoroughly mixed by vortexing, and a 2V voltage was applied using platinum wire (commercially available) as positive and negative electrodes, and the reaction was conducted at 25°C for 120 minutes. After the reaction, 10% of the total volume of 5 mol / L sodium chloride solution and 3 times of anhydrous ethanol were added to the reaction solution, and after being shaken evenly, it was placed in a refrigerator at -80°C for 2 hours, and then high-speed refrigerated centrifugation (4°C, 12000 rpm, 15 minutes), the supernatant was poured out, and the remaining precipitate was the product oligonucleic acid-sulfonamide compound (P14), which was detected by liquid chromatography-mass spectrometry. The detection results are shown in Fig.11 , molecular weight is 5389, and conversion rate is 89.0%.

[0075] An important difference between Example 2 and Example 1 is that R 3 , Example 1 represents an aromatic group, and Example 2 represents an aliphatic group. The amount of aliphatic sodium sulfinate used is relatively large relative to the amount of aromatic sodium sulfinate used. Therefore, the equivalent of sodium sulfinate is a relatively wide value of 50 to 1000 equivalents.

[0076] The difference from Example 1 / 2 is that oligonucleic acid-terminal amine compounds (1b-1f) are used as raw materials to react with different sodium sulfinate reagents (2a-2s) to synthesize other representative oligonucleic acid-sulfonamide structure compounds (P2-13, P15-24). The specific raw material structures are shown in Table 3. The test results of P2-13 and P15-24 are shown in Figure 7-14 .

[0077] Table 3

[0078]

[0079]

[0080] The inventors believe that, through creative labor, the experimental conditions of the present application have broken the conventional cognition of those skilled in the art. This is because the reaction conditions of the present application are suitable for preparing a variety of oligonucleic acid-sulfonamide structure compounds, which not only provides a relatively novel preparation method for oligonucleic acid-sulfonamide structure compounds, but also provides oligonucleic acid-sulfonamide structure compounds with richer structures, that is, R 3 It can be either aromatic or aliphatic, but the prior art only has most aromatics and some short-chain aliphatics, and the conversion rate of aliphatic substrates is low. 3When the reaction is aliphatic, the electron-donating effect makes the reaction difficult to proceed and the conversion rate is very low. However, in the experiment of this application, it is found that aliphatic can still proceed smoothly under the conditions of this application. Considering the structure of the actual compound to be used, R 3 The length is C2-C6.

[0081] 5. Integrity verification experiment of oligonucleic acid in the oligonucleic acid-sulfonamide structure compound of the present invention

[0082] Oligonucleic acid-sulfonamide structure compound P1 and oligo A (short-chain oligonucleotide, the molecular weight of the two chains is 4064 and 5884 respectively) are linked: 1 nanomole of P1 is dissolved in deionized water to prepare a solution with a concentration of 1 mmol / L (1 μl, 1 equivalent), and 1.2 equivalents of oligo A (1 mmol / L aqueous solution, 1.2 μl), 1 μl of 10×T4 DNA linking buffer solution and 0.5 μl of T4 DNA linking enzyme are added thereto. Then the above solutions are mixed evenly and reacted at room temperature for 1 hour. After the reaction is completed, 10% of the total volume of 5 mol / L sodium chloride solution is added to the reaction solution, and then 3 times the total volume of anhydrous ethanol is added. After shaking evenly, the reaction is placed in a refrigerator at -80°C and frozen for 2 hours. After that, centrifuge at a speed of 4000rpm for half an hour and pour off the supernatant. The remaining precipitate was dissolved in deionized water and then the molecular weight of the product oligoA-P1 was confirmed by liquid chromatography-mass spectrometry. The molecular weight was 15348. The mass spectrometry results are shown in Fig.15 .

[0083] The results of LCMS analysis show that the oligonucleic acid-sulfonamide structure compound P1 can be successfully coupled with oligo A. This indicates that the DNA chain integrity of the oligonucleic acid-sulfonamide structure compound obtained by the synthesis method described in this application is good. The molecular weight can be accurately displayed by LCMS mass spectrometry, further confirming that the reaction method of the present invention does not cause substantial damage to the basic structure and activity of DNA.

[0084] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make modifications to the present embodiment without any creative contribution as needed, but such modifications are protected by the patent law as long as they are within the scope of the claims of the present application.

Claims

1. A method for preparing On-DNA sulfonamide compounds by electrochemical reaction, It is characterized in that The method has the following reaction equation: Where -XY- is selected from R 1 is selected from the following groups: 5-6 membered aryl, 3-5 membered saturated cycloalkyl, 3-6 membered saturated heterocyclic group, C2-12 alkyl; R 2 Selected from the following groups: C2-8 alkyl, hydrogen atom; R 3 The invention relates to a method for preparing a novel oligonucleotide having a terminal amine compound of formula I and a substituted or unsubstituted group selected from the following groups: 5-6 membered aryl group, 5-6 membered heteroaryl group, 3-6 membered saturated cycloalkyl group, 3-6 membered saturated heterocyclic group, C2-12 alkyl group; wherein the substituent is halogen or alkyl group; the final concentration of the oligonucleic acid-terminal amine compound of formula I is 0.05-1.0 mmol / L; the equivalent of the sodium sulfinate reagent of formula II is 50-1000 equivalents; the electrolyte is selected from one of sodium iodide (NaI) or tetrabutylammonium iodide (TBAI), and the reagent equivalent is 50-300 equivalents; the reaction temperature is 0-35°C; the voltage is 0.5V-3.0V; the reaction solvent is any one of water, N,N-dimethylacetamide (DMA), dichloromethane (DCM), and dimethyl sulfoxide (DMSO) or a mixture of several thereof.

2. The method for preparing On-DNA sulfonamide compounds by electrochemical reaction according to claim 1, Its special feature is that The final concentration of the oligonucleic acid-terminal amine compound is 0.1 to 0.5 mmol / L.

3. The method for preparing On-DNA sulfonamide compounds by electrochemical reaction according to claim 1, It is characterized in that The equivalent weight of the sodium sulfite is 100 to 800 equivalent weights.

4. The method for preparing On-DNA sulfonamide compounds by electrochemical reaction according to claim 1, It is characterized in that The electrolyte equivalent is 100 to 300 equivalents.

5. The method for preparing On-DNA sulfonamide compounds by electrochemical reaction according to claim 1, It is characterized in that The reaction temperature is 15-30°C.

6. The method for preparing On-DNA sulfonamide compounds by electrochemical reaction according to claim 1, It is characterized in that The reaction time is 15 minutes or more.

Citation Information

Patent Citations

  • Synthetic method of On-DNA aryl sulfonamide compound in construction of DNA coding compound library

    CN110818749A

  • High efficiency small volume nucleic acid synthesis

    CN115927293A